The question remains of when such treatment should be given, and for this a scoring system can be useful. Since our own prognostic 'Fulham' score showed no significant mortality with conventional treatment on scores under 20, we would consider using CPAP with scores over 21.
Dr John L Watts (for Dr FS WBrimblecombe and Dr L Haas) (Royal Devon and Exeter Hospital, Exeter, EXJ 2ED): We have been using a modified, simplified version of the apparatus described by Gregory et al. (1971) . Air and oxygen can flow across a T-piece at the end of an endotracheal tube and pressure is both maintained and measured using an underwater seal. The infants are fed through a nasogastric tube where possible and arterial blood gases monitored through an umbilical arterial catheter.
We have treated 34 babies, 27 of these in 1972, and as an initial assessment we compared our mortality in 1972 and preceding years. In 1972, of 27 babies treated, 5 died; there were, as expected, more babies in the low birthweight group (see Table 1 ).
We first compared our neonatal mortality, exclusive of deaths due to major congenital mal- We also compared mortality rates in infants with respiratory distress, judged by the presence of cyanosis, tachypneea, grunting and intercostal recession. Here there has been a definite fall in mortality, from 15.5 % in 1968 to 10.8 % in 1972 -the fall in low birthweight infants with respiratory distress is even more striking, from 10% in 1968, our previous lowest recorded figure, to 6.6% in 1972. This does not prove the efficacy of CPAP but it is extremely encouraging and justifies the continuation of CPAP in a nonteaching hospital unit.
Finally we would point out the difficulty in assessing the effect of new techniques in an area where mortality rates are very low and would make a plea for the consideration of multicentre controlled trials in the assessment of such techniques.
